CRICO CRICO home

CRICO MDs ONLY: Register to access your facesheet, and more.

Advanced Search

  • Topic
  • Specialty
  • Content Type

RESET SEARCH CRITERIA

Also Related

< Back To Patient Safety
0 dislikes

< Hide

Comments For

References: Colorectal Cancer Decision Support Tool

0 comments

< Shrink

Add Your Voice

All comments are posted anonymously. Your comment will be attributed to: "Anonymous user."

post comment

Delete

Are you sure you want to delete this comment?

References: Colorectal Cancer Decision Support Tool

Related to: Clinical Guidelines, Communication, Diagnosis, Primary Care, Other Specialties

References 1–20
1. Burt RW. Colon Cancer Screening.
Gastroenterology. 2000;119:837–53.

2. Chung DC, Rustgi AK. The hereditary nonpolyposis colorectal cancer syndrome: genetics and clinical implications. Ann Intern Med. 2003;138:560–70.

3. Hampel H et al. Screening for the Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer). NEJM. 2005;352:1851–60.

4. Lubbe SJ et al. Clinical Implications of the Colorectal Cancer Risk Associated with MUTYH Mutation. J Clin Oncol. 2009;27:3975–80.

5. Jasperson KW et al. Hereditary and Familial Colon Cancer. Gastroenterology. 2010;138:2044–58.

6. Bernstein CN et al. Cancer risk in patients with inflammatory bowel disease: a population-based study. Cancer. 2001;91:854–62.

7. Beaugerie L et al. Risk of colorectal high grade dysplasia and cancer in a prospective observational cohort of patients with inflammatory bowel disease. Gastroenterology. 2013;145:166–75.

8. Farraye FA et al. AGA Technical review on the diagnosis and management of colorectal neoplasia
in inflammatory bowel disease. Gastroenterology. 2010;138:746–74.

9. Farraye FA et al. AGA Medical Position statement on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease. Gastroenterology. 2010;138:738–45.

10. Nishihara R et al. Long-term colorectal-cancer incidence and mortality after lower endoscopy. NEJM. 2013;369:1095–105.

11. Doubeni CA. et al. Screening colonoscopy and risk for incident late-stage colorectal cancer diagnosis in average risk adults. Ann Intern Med. 2013;158 (5 Part 1):312–20.

12. Shaukat A et al. Long-term mortality after screening for colorectal cancer. NEJM. 2013;369:1106–14.

13. Levin TR et al. Colorectal-cancer screeningcoming of age. NEJM. 2013:1164–66.

14. Whitlock EP et al. Screening for colorectal cancer: A targeted, updated systematic review for the U.S. Preventive Services Task Force. Ann Intern Med. 2008;149:638–58.

15. Zauber AG et al. Evaluating test strategies for colorectal cancer screening: A decision analysis for the U.S. Preventive Services Task Force. Ann Intern Med. 2008;149:659–69.

16. Brenner H et al. Protection from colorectal cancer after colonoscopy: a population-based, casecontrol study. Ann Intern Med. 2011; 154:22–30.

17. USPSTF. Screening for colorectal cancer: recommendation statement. Ann Intern Med. 2008:149:680–82. 

18. Zauber AG et al. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. NEJM. 2012;366:687–96.

19. Lieberman DA et al. Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on colorectal cancer. Gastroenterology. 2012;143:844–57.

20. Atkin WS et al. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet. 2010;375:1624–33. 
 References 21–40
21. Schoen RE et al. Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy NEJM. 2012;366:2345–57.

22. Qunitero E et al. Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening. NEJM. 2012;366:697–706.

23. Inadomi JM et al. Adherence to colorectal cancer screening. A randomized clinical trial of competing strategies. JAMA. 2012:172:575–82.

24. Lieberman DA et al. Prevalence of colon polyps detected by colonoscopy screening in asymptomatic black and white patients. JAMA. 2008;300:1459–61.

25. Agrawal S et al. Colorectal cancer in African Americans. Am J Gastroenterol. 2005;100:515–23.

26. Haggar FA, Boushey RP. Colorectal cancer epidemiology: Incidence, mortality, survival, and risk factors. Clin Colon Rectal Surg. 2009. 22;191–97.

27. Okabayashi K et al. Body mass index category as a risk factor for colorectal adenomas: a systematic review and meta-analysis. Am J Gastroenterol. 2012;107:1175–85

28. Henderson TO et al. Secondary gastrointestinal malignancies in childhood cancer survivors: a cohort study. Ann Intern Med. 2012;156:757–66.

29. Sheffield KM et al. Potentially inappropriate screening colonoscopy in Medicare patients. JAMA. 2013;173:542–50.

30. Torke AM et al. Older Adults and Forgoing Cancer Screening. 2013. JAMA. 2013;173:526–31.
31. Day LW et al. Adverse events in older patients undergoing colonoscopy: a systematic review and meta-analysis. Gastrointest Endosc. 2011;74:885–96.

32. Collins JF et al. Accuracy of screening for fecal occult blood on a single stool sample obtained
by digital rectal examination: a comparison with recommended sampling practice. Ann Intern Med.
2005;142:81–5.

33. Markowitz GS et al. Acute phosphate nephropathy following oral sodium phosphate bowel purgative: an underrecognized cause of chronic renal failure. J Am Soc Nephrol. 2005;16:3389–96.

34. Khurana A et al. The effects of oral sodium phosphate drug products on renal function in adults undergoing bowel endoscopy. Arch Intern Med. 2008:168(6):593–97.

35. Heher EC et al. Adverse renal and metabolic effects associated with oral sodium phosphate bowel preparation. Clin J Am Soc Nephrol. 2008;3:1494–1503.

36. Shields HM et al. Disparities in evaluation of patients with rectal bleeding 40 years and older. Clin Gastroenterol Hepatol. 2014, in press.

37. Gurudu SR et al. Increased adenoma detection rate with system-wide implementation of a splitdose preparation for colonoscopy. Gastrointest Endosc. 2012;76:603–8.

38. Rex DK et al. Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies. Gastroenterology. 1997;112:24–8.

39. Aslinia F et al. Quality Assessment of colonoscopic cecal intubation: An analysis of 6 years of continuous practice at a university hospital. Am J Gastroenterol. 2006;101:721–31.

40. Lee RH. Quality Colonoscopy: A matter of time, technique or technology? World J Gastroenterol. 2013;19:1517–22.

References 41–60
41. Kaminski MF et al. Quality indicators for
colonoscopy and the risk of interval cancer. NEJM. 2010.362:1795–1803

42. Brenner H et al. Role of colonoscopy and polyp characteristics in colorectal cancer after colonoscopic polyp detection. Ann Intern Med. 2012;157:225–32.

43. Robertson D et al. Using the results of a baseline and a surveillance colonoscopy to predict recurrent adenomas with high-risk characteristics. Ann Intern Med. 2009;151:103–9.

44. Rex DK et al. Serrated lesions of the colorectum: Review and recommendations from an expert panel. Am J Gastroenterol. 2012;107:1315–29.

45. Pohl H et al. Incomplete polyp resection during colonoscopy: Results of the complete adenoma resection (CARE) study. Gastroenterology. 2013;144:74–80.

46. National Comprehensive Cancer Network (NCCN) Guidelines Version 2.2012 Panel Members Colorectal Cancer Screening. NCCN.org.

47. Kahi CJ, Rex DK. Why we should CARE about polypectomy technique. Gastroenterology. 2013;144:16–8.

48. Baxter NM et al. Association of colonoscopy and death from colorectal cancer. Ann Intern Med. 2009;150:1–8.

49. Ransohoff DF et al. How much does colonoscopy reduce colon cancer mortality? Ann Intern Med. 2009;150:50–2.

50. Umar A et al. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch Syndrome) and microsatellite instability. J Natl Cancer Inst. 2004;96:261–68.
51. Mandel JS et al. Reducing mortality from colorectal cancer by screening for fecal occult blood: Minnesota Colon Cancer Control Study. NEJM. 1993;328:1365–71.

52. Hardcastle JD et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer.
Lancet. 1996;348:1472–77.

53. Kronborg O et al. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet. 1996; 348:1467–71.

54. Lieberman DA, Weiss DG. One-time screening for colorectal cancer with combined fecal occult blood testing and examination of the distal colon. NEJM. 2001;345:555–60.

55. Levi Z et al. A quantitative immunochemical fecal occult blood test for colorectal neoplasia. Ann Intern Med. 2007;146:244–55.

56. Morikawa T et al. A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population. Gastroenterology. 2005;129:422–28.

57. Hundt S, Haug U, Brenner H. Comparative Evaluation of immunochemical fecal occult blood tests for colorectal adenoma detection. Ann Intern Med. 2009;150:162–69.

58. Liles EG et al. Change to FIT increased CRC screening rates: Evaluation of a US screening outreach program. Am J Manag Care. 2012;18: 588–595.

59. Denters MJ et al. Lower risk of advanced neoplasia among patients with a previous negative result from a fecal test for colorectal cancer. Gastroenterology. 2012;142:497–504.

60. Lieberman DA et al. Use of colonoscopy to screen asymptomatic adults for colorectal cancer: Veterans Affairs Cooperative Study 380. NEJM. 2000;343:162–68.

References 61–71
61. Imperiale TF et al. Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings. NEJM. 2000;343:169–74.

62. Gatto NM et al. Risk of perforation after colonoscopy and sigmoidoscopy: a population based study. J Natl Cancer Inst. 2003;95:230–36.

63. Anderson ML, Pasha TM, Leighton JA. Endoscopic perforation of the colon: lessons for a 10–year study. Am J Gastroenterol. 2000;95:3418–22.

64. Barclay RL et al. Colonoscopic withdrawal times and adenoma detection during screening colonoscopy. NEJM. 2006;355:2533–41.

65. Sawhney MS et al. Effect of institution-wide policy of colonoscopy withdrawal time > 7 minutes on polyp
66. Pickhardt PJ et al. Computed tomographic virtual colonoscopy to screen for colorectal neoplasia in asymptomatic adults. NEJM. 2003;349:2191–200.

67. Johnson CD et al. Prospective blinded evaluation of computed tomographic colonography for screen detection of colorectal polyps. Gastroenterology. 2003;125:311–19.

68. Zalis ME et al. Diagnostic accuracy of laxativefree computed tomographic colonography for detection of adenomatous polyps in asymptomatic adults: A prospective evaluation. Ann Intern Med. 2012;156:692–702.

69. Cash BD et al. Clinical Use of CT colonography for colorectal cancer screening in military training facilities and potential impact on

70. Graser A et al. Magnetic resonance colonography for the detection of colorectal neoplasia in asymptomatic adults. Gastroenterology. 2013;144:743–50.

71. Bresalier RS. Colorectal Cancer. In: Sleisenger and Fordtran’s Gastrointestinal and Liver Disease. Ninth Edition. Eds. Mark Feldman, Lawrence S. Friedman, Lawrence J. Brandt. Philadelphia, Saunders Elsevier. 2010. p. 2208.

March 4, 2014
0 dislikes

< Back To Patient Safety